Adial Pharmaceuticals Inc (ADIL) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Adial Pharmaceuticals Inc, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$5.05
+36.12% today
Market cap
$10M
Overall quality
53/100
Kronos AI 30-day
−0.2%
4 of 8 simulated paths end higher
Adial Pharmaceuticals Inc (ADIL) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $10M. It trades at $5.05, up 36.12% today. Its overall quality score is 53 out of 100, ranked against the whole US market. 1 analysts' average target of $11.00 implies +117.8% from today's price. Kronos AI's 30-day forecast is −0.2% (4 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $11.00 |
| Low – high | $11.00 – $11.00 |
| Analysts | 1 |
| Upside to average | +117.8% |
Kronos AI 30-day forecast
| Expected close | $3.70 (−0.2%) |
| Likely range | −16.7% … +6.7% |
| As of | 2026-10-27 |
4 of 8 simulated paths end higher.
Quality scores
| Profitability | 33 |
| Solvency | 78 |
| Growth | 48 |
| Overall | 53 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.